Answers are grounded in this paper and cite their sources.
Background Recurrence, recanalization, reperfusion, or retreatment remains an important durability limitation after endovascular treatment of intracranial aneurysms. Most recurrence studies characterize blood pressure exposure as a history or study-defined diagnosis of hypertension rather than achieved post-treatment systolic or diastolic blood pressure. Objective To quantify the association between study-defined/history-based hypertension status and recurrence-related outcomes after endovascular aneurysm treatment, and to separately summarize indirect clinical evidence on achieved blood pressure, blood pressure variability, and mechanistic hemodynamic evidence. Methods PubMed/MEDLINE, Ovid MEDLINE, and Embase were searched from database inception through April 2026. The direct recurrence synthesis included adult endovascular aneurysm cohorts reporting recurrence-related outcomes according to hypertension status. Indirect clinical studies of achieved blood pressure or blood pressure variability and mechanistic computational-fluid-dynamics studies were synthesized separately. Odds ratios (ORs) for the direct recurrence analysis were pooled using inverse-variance random-effects models with restricted maximum-likelihood estimation and Hartung-Knapp adjustment. Study selection was independently performed by two reviewers at title/abstract and full-text stages; unresolved disagreements were adjudicated by a third reviewer. Results Thirty-one studies were included. Eight studies provided extractable 2 × 2 data for the primary recurrence-related analysis (2,442 observations: 1,231 in the hypertension/high-BP-status group and 1,211 in the non-hypertension group; 559 recurrence-related events overall, 242 and 317 respectively). Study-defined hypertension showed a directionally higher but statistically non-significant association with recurrence/recanalization/reperfusion (OR 1.36, 95% CI 0.92–2.00; p = 0.104; I 2 = 31.4%). No eligible recurrence study reported recurrence according to achieved SBP/DBP target categories. The overlapping full and matched Lee 2021 controlled-versus-uncontrolled hypertension estimates were presented separately and were not pooled. BP-variability studies addressed heterogeneous clinical outcomes and were not quantitatively pooled. Conclusion Current evidence is insufficient to establish study-defined hypertension as an independent predictor of recurrence after endovascular aneurysm treatment or to recommend a recurrence-preventive blood pressure target. The available direct evidence concerns predominantly history-based hypertension status, whereas achieved blood pressure and blood pressure variability evidence is indirect for angiographic recurrence.
No takes yet. Share an insight, caveat, or question.
Pan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: